Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v9-FR
Language English French
Date Updated 2023-07-06 2022-09-07
Drug Identification Number 02144298 02144298
Brand name TEVA-TRAZODONE TEVA-TRAZODONE
Common or Proper name TEVA-TRAZODONE 150MG COMP TABS TEVA-TRAZODONE 150MG COMP TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TRAZODONE HYDROCHLORIDE TRAZODONE HYDROCHLORIDE
Strength(s) 150MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-16 2022-06-16
Estimated end date 2023-06-20 2022-11-10
Actual end date 2023-07-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments